Click for best price
Human Microbiome Based Drugs Diagnostics Market Size, Share 2023
| Market size in 2022 |
US$ 851.9 million
|
Forecast Market size by 2029 |
US$ 1647 million
|
| Growth Rate |
CAGR of 9.9% |
Number of Pages |
60 Pages |
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Based Drugs and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Based Drugs and Diagnostics. This report contains market size and forecasts of Human Microbiome Based Drugs and Diagnostics in global, including the following market information:
Global Human Microbiome Based Drugs and Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Microbiome Based Drugs and Diagnostics market was valued at US$ 851.9 million in 2022 and is projected to reach US$ 1647 million by 2029, at a CAGR of 9.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising cases of chronic diseases such as diabetes, disorders at early stage and the ability of the drugs to diagnose them and increased awareness among people to maintain healthy lifestyle is driving the growth of this market.
We surveyed the Human Microbiome Based Drugs and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Microbiome Based Drugs and Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, by Type, 2022 (%)
Therapeutics
Diagnostics
Global Human Microbiome Based Drugs and Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Research Institutes
Hospital
Surgical Centers
Others
Global Human Microbiome Based Drugs and Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Microbiome Based Drugs and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Microbiome Based Drugs and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Second Genome
Enterome Bioscience
Yakult
Dowdupont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Microbiome Based Drugs and Diagnostics, market overview.
Chapter 2: Global Human Microbiome Based Drugs and Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Human Microbiome Based Drugs and Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Microbiome Based Drugs and Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Microbiome Based Drugs and Diagnostics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 851.9 million
|
| Forecast Market size by 2029 |
US$ 1647 million
|
| Growth Rate |
CAGR of 9.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Microbiome Based Drugs and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Microbiome Based Drugs and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Microbiome Based Drugs and Diagnostics Overall Market Size
2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size: 2022 VS 2029
2.2 Global Human Microbiome Based Drugs and Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Microbiome Based Drugs and Diagnostics Players in Global Market
3.2 Top Global Human Microbiome Based Drugs and Diagnostics Companies Ranked by Revenue
3.3 Global Human Microbiome Based Drugs and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Based Drugs and Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Microbiome Based Drugs and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Human Microbiome Based Drugs and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Microbiome Based Drugs and Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Therapeutics
4.1.3 Diagnostics
4.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2022 & 2029
5.1.2 Clinical Research Institutes
5.1.3 Hospital
5.1.4 Surgical Centers
5.1.5 Others
5.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.3.2 US Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.3.3 Canada Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.3.4 Mexico Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.4.2 Germany Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.3 France Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.4 U.K. Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.5 Italy Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.6 Russia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.8 Benelux Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.5.2 China Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.3 Japan Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.4 South Korea Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.6 India Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.6.2 Brazil Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.6.3 Argentina Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.7.2 Turkey Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.3 Israel Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.5 UAE Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
7 Human Microbiome Based Drugs and Diagnostics Companies Profiles
7.1 Second Genome
7.1.1 Second Genome Company Summary
7.1.2 Second Genome Business Overview
7.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.1.4 Second Genome Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Second Genome Key News & Latest Developments
7.2 Enterome Bioscience
7.2.1 Enterome Bioscience Company Summary
7.2.2 Enterome Bioscience Business Overview
7.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.2.4 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Enterome Bioscience Key News & Latest Developments
7.3 Yakult
7.3.1 Yakult Company Summary
7.3.2 Yakult Business Overview
7.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.3.4 Yakult Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Yakult Key News & Latest Developments
7.4 Dowdupont
7.4.1 Dowdupont Company Summary
7.4.2 Dowdupont Business Overview
7.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.4.4 Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Dowdupont Key News & Latest Developments
7.5 Vedanta BioSciences
7.5.1 Vedanta BioSciences Company Summary
7.5.2 Vedanta BioSciences Business Overview
7.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.5.4 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Vedanta BioSciences Key News & Latest Developments
7.6 Metabiomics Corporation
7.6.1 Metabiomics Corporation Company Summary
7.6.2 Metabiomics Corporation Business Overview
7.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.6.4 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Metabiomics Corporation Key News & Latest Developments
7.7 ViThera Pharmaceuticals
7.7.1 ViThera Pharmaceuticals Company Summary
7.7.2 ViThera Pharmaceuticals Business Overview
7.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.7.4 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.7.5 ViThera Pharmaceuticals Key News & Latest Developments
7.8 MicroBiome Therapeutics
7.8.1 MicroBiome Therapeutics Company Summary
7.8.2 MicroBiome Therapeutics Business Overview
7.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.8.4 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.8.5 MicroBiome Therapeutics Key News & Latest Developments
7.9 Osel
7.9.1 Osel Company Summary
7.9.2 Osel Business Overview
7.9.3 Osel Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.9.4 Osel Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Osel Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.10.4 Merck Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Microbiome Based Drugs and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Human Microbiome Based Drugs and Diagnostics Market Drivers in Global Market
Table 3. Human Microbiome Based Drugs and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Human Microbiome Based Drugs and Diagnostics in Global Market
Table 5. Top Human Microbiome Based Drugs and Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Microbiome Based Drugs and Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Microbiome Based Drugs and Diagnostics Product Type
Table 9. List of Global Tier 1 Human Microbiome Based Drugs and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Second Genome Company Summary
Table 31. Second Genome Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 32. Second Genome Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Second Genome Key News & Latest Developments
Table 34. Enterome Bioscience Company Summary
Table 35. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 36. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Enterome Bioscience Key News & Latest Developments
Table 38. Yakult Company Summary
Table 39. Yakult Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 40. Yakult Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Yakult Key News & Latest Developments
Table 42. Dowdupont Company Summary
Table 43. Dowdupont Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 44. Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Dowdupont Key News & Latest Developments
Table 46. Vedanta BioSciences Company Summary
Table 47. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 48. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Vedanta BioSciences Key News & Latest Developments
Table 50. Metabiomics Corporation Company Summary
Table 51. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 52. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Metabiomics Corporation Key News & Latest Developments
Table 54. ViThera Pharmaceuticals Company Summary
Table 55. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 56. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. ViThera Pharmaceuticals Key News & Latest Developments
Table 58. MicroBiome Therapeutics Company Summary
Table 59. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 60. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. MicroBiome Therapeutics Key News & Latest Developments
Table 62. Osel Company Summary
Table 63. Osel Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 64. Osel Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Osel Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 68. Merck Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
List of Figures
Figure 1. Human Microbiome Based Drugs and Diagnostics Segment by Type in 2022
Figure 2. Human Microbiome Based Drugs and Diagnostics Segment by Application in 2022
Figure 3. Global Human Microbiome Based Drugs and Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Microbiome Based Drugs and Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2022
Figure 8. By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Second Genome Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Yakult Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Osel Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
